NCT02437981Enrolling by invitation
Evaluation of PrEP-30: a Demonstration Project of Pre-exposure Prophylaxis for MSM and Other High-risk Group Clients at the Thai Red Cross Anonymous Clinic
Thai Red Cross AIDS Research Centre (TRC-ARC)
Source: ClinicalTrials.gov · Last updated 25 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
PrEP-30 is a demonstration project to assess the feasibility of providing oral PrEP to MSM and other individuals at-risk for HIV in Bangkok, Thailand as a service that is funded entirely through user fees. Tenofovir disoproxil fumarate/emtricitabine PrEP is provided part of a combined HIV prevention program that includes risk-reduction counseling, regular HIV testing, and the provision of condoms and lubricants. PrEP-30 is implemented at the Thai Red Cross AIDS Research Centre, at the site of the largest HIV counseling and testing center in Thailand.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 20000 (estimated)
- First submitted
- 24 Apr 2015
- Start date
- 1 Dec 2014
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Thai Red Cross AIDS Research Centre
- Diseases
- HIV
- NCT number
- NCT02437981
What you commit to
- Study type: Observational
- Planned participants: 20000
- From 1 Dec 2014 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Age \> 18 years
- HIV test negative
- Creatinine clearance \> 60 ml/min
- No contraindication or allergy to PrEP medications (TDF/FTC)
- At least one risk factor for HIV infection within the previous 6 months:
- sex partner known to be HIV positive
- works as commercial sex worker
- use of PEP for sexual exposure
- injection drug use
- any STI (syphilis, gonorrhea, chlamydia)
- \> 5 sex partners
- inconsistent condom use with high-risk partners, including MSM, IDU
- MSM: any insertive or receptive anal sex without condom
- Women: any sex without condom with high-risk male partner (MSM, IDU, multiple female partners)
- Heterosexual men: any sex without condom with high-risk female partner (commercial sex worker, IDU, multiple male partners)
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Thai Red Cross AIDS Research Centre Coordinator of this site? Confirm its status | Bangkok | Thailand | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.